Related Experiment Video
Updated: Jun 27, 2025
08:47
Rapid Viscoelastic Characterization of Airway Mucus Using a Benchtop Rheometer
Published on: April 21, 2022
3.3K
Emerging cell and molecular targets for treating mucus hypersecretion in asthma
Ana M Jaramillo1, Eszter K Vladar1, Fernando Holguin1
1Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado School of Medicine, Aurora, CO, USA.
Summary
Abnormal mucus in asthma hinders treatment by blocking airways. Understanding mucin glycoproteins (MUC5AC, MUC5B) production and secretion by epithelial cells is key to developing new mucus-targeting therapies.
Area of Science:
- Pulmonary Medicine
- Cell Biology
- Biochemistry
Background:
- Mucus is vital for lung defense but excessive mucus causes disease.
- Asthma treatments inadequately address mucus hypersecretion and airway plugging.
- Current therapies do not directly target mucus production or clearance.
Purpose of the Study:
- To review recent advances in mucin glycoprotein biology.
- To focus on MUC5AC and MUC5B, key components of airway mucus.
- To identify novel therapeutic strategies by understanding mucin secretion.
Main Methods:
- Literature review of recent scientific advances.
- Focus on epithelial cell biology related to mucus.
- Analysis of mucin production and secretion mechanisms.
Main Results:
- Mucin glycoproteins MUC5AC and MUC5B are central to airway mucus.
- Epithelial cells play a critical role in mucus synthesis, secretion, and transport.
- Understanding these processes is crucial for addressing mucus-related pathologies.
Conclusions:
- Targeting mucus hypersecretion requires a deeper understanding of mucin biology.
- Novel therapeutic strategies can emerge from studying mucin production and secretion.
- Focusing on epithelial cell mechanisms offers potential for improved asthma treatment.
Related Concept Videos
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
279
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
279
01:20Asthma: Pathogenesis and Management
390
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
390
01:26Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
01:29Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
01:20Antiasthma Drugs: Muscarinic Receptor Antagonists
289
Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
289
01:16Drugs Used in Upper Respiratory Disorders: Overview
234
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
234